ACGL
Arch Capital Group Ltd.
ACGL trails on the overall score without a compensating advantage in the available component scores.
BAC
Bank of America Corporation
BAC has the edge over ACGL overall, supported by stronger modeled upside and stronger fundamentals.
ACGL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| N/A | |
| N/A |
ACGL's profitability is currently strong, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like ACGL.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ACGL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.8x | $95.05 | -13% |
| Current | 9x | $109 | — |
| Fair | 9.3x | $113 | +3.8% |
| Forward | 11x | $109 | — |
| Expensive | 12x | $152 | +40% |
Historical ranges are pointers, not guarantees.
ACGL has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
ACGL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect ACGL's profitability to improve, but its revenue to decline.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ACGL on the outlook, with more favorable valuation and earnings expectations.
ACGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.79 | -20% |
| Q3 2026 | $12.21 | +14% |
| Q2 2026 | $12.77 | +32% |
| Q1 2026 | $13.00 | +33% |
| Q4 2025 | $11.60 | +3.7% |
| Q3 2025 | $10.68 | -28% |
| Q2 2025 | $9.68 | -32% |
| Q1 2025 | $9.75 | -23% |
| Q4 2024 | $11.19 | -3.7% |
ACGL earned $12.21 per share over the past year, up 14% from the year before.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over ACGL on earnings, with more consistent year-over-year improvement.
ACGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.7B | -8.9% |
| Q2 2026 | $4.7B | -10% |
| Q1 2026 | $4.5B | -3.3% |
| Q4 2025 | $4.9B | +8.5% |
| Q3 2025 | $5.1B | +8.2% |
| Q2 2025 | $5.2B | +23% |
| Q1 2025 | $4.7B | +19% |
| Q4 2024 | $4.5B | +14% |
ACGL's revenue grew through 2024 and has held roughly level since: $4.7B last quarter, down 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2021 | 38% | +12 points |
| Q3 2021 | 14% | -7.8 points |
| Q2 2021 | 29% | +7.5 points |
| Q1 2021 | 19% | +23 points |
| Q4 2020 | 27% | +7 points |
| Q3 2020 | 22% | N/A |
| Q2 2020 | 21% | N/A |
| Q1 2020 | -4% | N/A |
ACGL's operating margin was 38% last quarter, up 12 points from the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over ACGL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ACGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.7B | -20% |
| Q2 2026 | $1.3B | +18% |
| Q1 2026 | $1.2B | -19% |
| Q4 2025 | $1.4B | -11% |
| Q2 2025 | $1.1B | -26% |
| Q1 2025 | $1.4B | -6.5% |
| Q4 2024 | $1.6B | -5.5% |
| Q2 2024 | $1.5B | +33% |
ACGL has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ACGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -7.4M shares |
| 1 year | -9.2% | -34.7M shares |
| 3 years | -10% | -38M shares |
| 5 years | -14% | -56.5M shares |
| Available history | -17% | -70.2M shares |
ACGL has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.4B |
| Q2 2026 | $1.2B |
| Q1 2026 | $783M |
| Q4 2025 | $798M |
| Q3 2025 | $732M |
| Q2 2025 | $163M |
| Q1 2025 | $196M |
| Q4 2023 | — |
ACGL spent $4.2B buying back its own shares over the past year.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ACGL Net Leverage
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ACGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.0 | Neutral |
| Stochastic | 81.6 | Overbought |
ACGL's weekly RSI is 69 (neutral) and its Stochastic is 82 (overbought).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ACGL PE vs Financial Services Sector
| Metric | ACGL | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 13x | 31% below |
| PE % | 42 | 63 | 21 pts below |
ACGL has the edge over BAC on valuation relative to its sector.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ACGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $101.2 | 7.9% above |
| 20 week MA | $100.2 | 9% above |
| 50 week MA | $97.0 | 13% above |
| 100 week MA | $94.1 | 16% above |
| 200 week MA | $90.1 | 21% above |
ACGL has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ACGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.6 | $34.9 | -18% |
| 2021 | $34.9 | $43.5 | +25% |
| 2022 | $43.5 | $63.4 | +46% |
| 2023 | $63.4 | $74.3 | +17% |
| 2024 | $74.3 | $92.3 | +24% |
| 2025 | $92.3 | $95.9 | +3.8% |
| 2026 YTD | $95.9 | $109.2 | +14% |
ACGL has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.